DMCC Speciality Chemicals Limited has disclosed the contact details of its Key Managerial Personnel (KMP) in compliance with SEBI regulations. The company informed both NSE and BSE on January 10, 2026, about the Board of Directors' authorization of four key executives for regulatory disclosure purposes.

Board Authorization and Regulatory Compliance

The Board of Directors meeting held on January 10, 2026, authorized specific Key Managerial Personnel for determining materiality of events and information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure ensures compliance with Regulation 30(5) of the SEBI LODR regulations, which mandates companies to provide contact details of authorized personnel for regulatory communications.

Key Managerial Personnel Details

The company has designated four senior executives as authorized KMP for regulatory disclosure purposes:

Leadership Transition

A notable aspect of this disclosure is the appointment of Ms Pallavi Pednekar as Company Secretary & Compliance Officer, with her role commencing from January 27, 2026. This indicates a planned leadership transition in the company's compliance function, ensuring continuity in regulatory oversight and corporate governance.

Corporate Communication Framework

The disclosure establishes a clear communication framework for regulatory matters, with all four KMP sharing the same primary contact number (+91 22 22048882/3) while maintaining individual email addresses for specific departmental communications. This structure facilitates efficient handling of regulatory queries and ensures appropriate escalation channels for material information disclosure to stock exchanges.

DMCC Speciality Chemicals Limited has announced key leadership appointments following its board meeting held on January 10, 2026. The company has strengthened its board composition with the addition of an independent director and appointed a new company secretary to enhance corporate governance.

Board Appointments Overview

The board meeting, which commenced at 11:35 AM IST and concluded at 1:40 PM IST, resulted in two significant appointments made pursuant to Regulation 30 of SEBI Listing Obligations and Disclosure Requirements, 2015.

Independent Director Appointment

Ms. Saloni Jhaveri has been appointed as Additional Director, designated as Non-Executive Independent Director, based on the recommendation of the Nomination and Remuneration Committee. Her appointment is subject to shareholder approval and represents a first term of five consecutive years.

Ms. Jhaveri brings over two decades of experience in private equity, mergers and acquisitions, corporate finance, and strategy, with professional experience spanning the United States and India. She has successfully executed and closed several cross-border and domestic transactions, including mergers, acquisitions, joint ventures, and private equity investments across multiple sectors.

Professional Background

• Current Role: Heads Investor Relations at NIIF, responsible for fundraising across all three funds
• Previous Experience: Partner at SKP Business Consulting, KPMG India, HDFC Private Equity, and Praxair (USA)
• Education: Bachelor's and Master's degree in Commerce from Sydenham College of Commerce and Economics, MBA from The Pennsylvania State University

Company Secretary Appointment

Ms. Pallavi Pednekar has been appointed as Company Secretary & Compliance Officer and Key Managerial Personnel pursuant to Section 203 of the Companies Act, 2013. Her appointment becomes effective from January 27, 2026.

Regulatory Compliance

Both appointments have been made in compliance with regulatory requirements. The company has confirmed that Ms. Saloni Jhaveri is not debarred from holding the office of Director by virtue of any SEBI order or any other authority, as required pursuant to BSE and NSE circulars dated June 20, 2018.

The appointments reflect the company's commitment to strengthening its governance structure and leadership capabilities as it continues its business operations in the specialty chemicals sector.